Border Collie Health: CEA, Hip Dysplasia & Mental Stimulation
Updated June 2026
- Lifespan: 12–15 years
- Top Health Risks: Collie eye anomaly (CEA), hip dysplasia, epilepsy, trapped neutrophil syndrome, neuronal ceroid lipofuscinosis
- Genetic Tests Recommended: CEA/CH DNA test, TNS DNA test, NCL DNA test, MDR1 (ABCB1) DNA test, OFA hip/elbow, BAER hearing test
Border Collies are widely regarded as the most intelligent of all domestic dog breeds, and their physical and mental athleticism makes them outstanding working and sporting dogs. However, this highly specialised breed carries a notable number of hereditary conditions, many of which can be screened by DNA test before a puppy is purchased. Understanding the breed's health profile — both physical and behavioural — is essential for anyone considering sharing their life with one of these remarkable dogs.
Most Common Health Problems in Border Collies
Collie eye anomaly (CEA) is the most prevalent hereditary condition in the breed globally, affecting a substantial proportion of Border Collies. Hip dysplasia, while less prevalent than in some larger breeds, causes significant problems in working and sport dogs. Idiopathic epilepsy has a hereditary component and is over-represented in Border Collies. Two serious metabolic genetic conditions — trapped neutrophil syndrome (TNS) and neuronal ceroid lipofuscinosis (NCL) — are fatal without early identification. Drug sensitivity due to the MDR1 (ABCB1) mutation creates important prescribing considerations. Beyond physical disease, behavioural and compulsive disorders driven by unmet mental stimulation needs represent a major welfare concern in the breed.
Collie Eye Anomaly (CEA)
CEA is a spectrum of congenital eye abnormalities caused by a mutation in the NHEJ1 gene, inherited autosomal recessively. The mildest form — choroidal hypoplasia — causes thinning of the vascular layer beneath the retina and may cause no functional impairment. More severe forms include coloboma (pit or hole in the optic disc or sclera), optic disc defects, and in the worst cases, retinal detachment leading to blindness. Most affected Border Collies have the mild form and live visually normal lives. DNA testing identifies clear, carrier, and affected dogs; responsible breeders do not mate two carriers together. CAER ophthalmological examination at five to eight weeks of age (before the choroid fully pigments and "masks" the lesion) is the traditional diagnostic method alongside DNA testing.
Hip Dysplasia
Approximately 12% of Border Collies evaluated by the OFA show some degree of hip dysplasia. In a working sheep dog or agility competitor, even moderate hip dysplasia has significant functional consequences that would not be as apparent in a pet of comparable size. Hip dysplasia in Border Collies manifests as reduced hindlimb drive, reluctance to jump, and progressive lameness. OFA hip certification of both parents is standard practice among responsible breeders. For working-line dogs, BVA/KC Hip Dysplasia Scheme scores provide the UK equivalent. Management mirrors that for other breeds: controlled exercise, weight management, physiotherapy, anti-inflammatory medication, and surgical options for severe cases. Building core and hindlimb muscle mass through targeted conditioning exercises helps support dysplastic hips throughout a dog's active career.
Epilepsy and Neurological Conditions
Idiopathic epilepsy is over-represented in Border Collies, with a hereditary basis that is not yet fully characterised genetically. Onset is typically between one and five years of age. Most epileptic Border Collies can be well controlled on anticonvulsant medication and maintained in their working or sporting roles with appropriate management. Neuronal ceroid lipofuscinosis (NCL), by contrast, is a fatal progressive neurodegenerative storage disease. The Border Collie form (CL5) is caused by a mutation in the CLN5 gene and presents with progressive visual impairment, ataxia, behavioural change, and dementia, typically from 15–18 months of age. Death usually follows within 12–24 months of onset. A DNA test is available and allows complete elimination of the condition through responsible breeding.
Drug Sensitivity (MDR1/ABCB1 Mutation)
The MDR1 mutation impairs the P-glycoprotein pump that normally prevents certain drugs from accumulating to toxic levels in the brain. Border Collies with one or two copies of the mutation may experience severe neurological toxicity from drugs that are routinely safe in other breeds, including ivermectin (in antiparasitic doses), loperamide (Imodium), and several chemotherapy agents. A DNA test is available and is highly recommended, particularly for dogs that may receive chemotherapy or travel to regions where high-dose ivermectin antiparasitic products are used. Always inform your veterinarian of your dog's MDR1 status before prescribing any of the implicated drugs.
Mental Stimulation: A Health Imperative
Border Collies were bred to work all day in complex, cognitively demanding roles. Without sufficient physical exercise and mental stimulation, they develop stereotypic behaviours — compulsive ball chasing, shadow or light chasing, spinning, and obsessive herding — that cause genuine distress and are extremely difficult to resolve once established. These are not behavioural "problems" so much as medical manifestations of an unmet biological need. Before acquiring a Border Collie, honestly assess whether you can provide two or more hours of vigorous, varied activity daily including training, scent work, agility, herding, or similar cognitively demanding pursuits. Puzzle feeders, trick training, and nose work games supplement physical exercise but do not replace it.
Recommended Supplements for Border Collies
Omega-3 fatty acids (fish oil, 30–40 mg/kg EPA+DHA) support joint health in a breed whose athletic career puts sustained demands on hips and elbows. For Border Collies in active competition or herding work, joint support supplements including glucosamine, chondroitin, and green-lipped mussel extract are commonly used as preventive measures during high-mileage seasons. Antioxidants including vitamin E and coenzyme Q10 are sometimes recommended by veterinary neurologists for dogs with epilepsy as adjunctive support, though this should always be discussed with the managing veterinarian. Ensuring optimal omega-3 intake also supports the high neurological demands of a breed known for exceptional cognitive performance.
Some owners report benefits from CBD oil for joint discomfort — always discuss with your vet first and choose a THC-free product like Candid Tails.
For high-quality breed-specific nutrition and supplements, browse the selection at Zooplus — one of Europe's leading pet supply retailers.
Key Takeaways
- CEA is the most common hereditary condition in Border Collies — DNA testing before purchase is standard and eliminates uncertainty.
- The MDR1 mutation causes potentially fatal drug reactions — test all Border Collies and inform every vet of their status.
- NCL is a fatal neurological disease with a DNA test available; purchasing from tested-clear parents eliminates this condition entirely.
- Insufficient mental stimulation causes compulsive behaviours that are very difficult to reverse — only get a Border Collie if you can meet their extraordinary activity needs.
- Omega-3 supplementation and joint conditioning are important for the long-term athletic career of this highly active breed.
References
- Lequarré AS, Andersson L, André C, et al. LUPA: a European initiative taking advantage of the canine genome architecture for unravelling complex disorders in both human and dogs. Vet J. 2011;189(2):155-159. PMID: 21546278
- Mealey KL, Bentjen SA, Gay JM, Cantor GH. Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenetics. 2001;11(8):727-733. PMID: 11692082